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Palmitic acidAbstract Mitragyna speciosa Korth., is a controversial plant that possesses various medicinal val-
ues and has been used from time immemorial in folk medicine. Recently, it has been widely abused as
a narcotic source. The aim of the present study was to characterize the in vitro nitric oxide (NO) inhi-
bition property of the supercritical CO2 fluid extracts from M. speciosa leaves and to identify the
chemical constituents of the extract that exhibited the most inhibition without toxicity effect. Sam-
ples were extracted using the green technology, supercritical fluid extraction (SFE) technique via CO2
as the mobile phase. The NO inhibitory activity was evaluated by Griess assay, which measures the
formation of nitrite ion (NO2
) in recombinant mouse interferon gamma/lipopolysaccharide (IFN-c/
LPS) stimulated RAW 264.7 cells. Matrix 5 Step-1 (M5S1) that was extracted with pure CO2 at
3000 psi and 60 C exhibited the highest NO inhibitory activity (60.08%) without cytotoxicity (cell
viability, 91.98%) at a concentration of 100 lg/mL. GC and GC–MS analysis revealed palmitic acid
as the major constituent (34.90%) of M5S1. This study provides first evidence that M5S1, the non-
alkaloidal extract obtained by supercritical fluid extraction ofM. speciosa leaves possesses potential
property in preventing inflammatory diseases mediated by excessive production of NO.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).603 796
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Inflammation, a healing response of the body to various insults, is a
two edged sword. While it is typically recognized as a process for the
remission of diseases, the persistence of this process may lead to vari-
ous diseases associated with chronic inflammation. Nitric oxide (NO)
is a major signalling molecule of mammalian cells that plays an impor-
tant role in host defence, homeostasis and developmental functions by
either direct or indirect effects. Under normal physiological conditions,
cells containing constitutive isoforms of nitric oxide synthases (NOS),
i.e., endothelial NOS (eNOS) or neuronal NOS (nNOS) produce rela-
tively small but significant amounts of NO. In inflammatory condi-
tions, the inducible isoform of NOS (iNOS) is upregulated giving
rise to cellular NO concentration more than 10 lM (Burgner et al.,
1999). NO is a key signalling molecule in central and peripheral mech-
anism of pain. Excessive production of NO is linked to various patho-
logical conditions, including lipid peroxidation, DNA damage and
enzyme inhibition (Ratajczak-Wrona et al., 2013; Wink and
Mitchell, 1998). There are several reports on the direct role of excessive
NO production by macrophages as a contributing factor in a number
of chronic inflammatory diseases including arthritis, hepatitis, septic
and haemorrhagic shock and certain autoimmune disorders (Boveris
et al., 2002; Koulentaki et al., 2004; McDonald et al., 2003; Onur
et al., 2001). To date, the over expression of iNOS and/or its catalytic
activity in human tumour tissues has been established (Franco et al.,
2004; Loibl et al., 2005; Wang et al., 2003). Therefore, NO is a pivotal
chemical indicator of inflammation and inflammatory diseases.
Mitragyna speciosa Korth (locally known as ‘ketum’ or ‘biak’)
belongs to the family Rubiaceae and is native to the swampy regions
in Asia and Africa (Shellard, 1989). This plant can be found largely
in Thailand and Malaysia, reaching a height of 15 m, with a spread
over 5 m. The stem is erect and branched. The flowers are yellow
and spherical. The leaves are dark glossy green and their veins are
either greenish-white or red. This plant has application in traditional
practice for the treatment of muscle pain, fever, wounds, diarrheal,
cough and hypertension (Burkill, 1935; Burkill and Haniff, 1930;
Philipp et al., 2010). In folk medicine, the decoction of the leaves is
used as a tonic along with its use as a substitute for opium or morphine
(Burkill, 1935; Holmes, 1895; Jansen and Prast, 1988a, 1988b;
Suwanlert, 1975). The plant has long been considered unusual for its
dual properties as a stimulant and sedative. In Thailand and Malaysia,
the leaves are used for its coca-like stimulant ability to combat fatigue
and to enhance tolerance to hard work under intense sunlight (Grewal,
1932; Suwanlert, 1975). The greenish-white veined variety is claimed to
possess stronger effect as a stimulant (Suwanlert, 1975). Meanwhile,
the sedative opium-like effects were experienced if consumed at large
doses and this can be used to treat pain and opium withdrawal
(Boyer et al., 2008; Wray, 1907a, 1907b). Till present, scientific
research has only communicated mainly on the anaesthetic, antitus-
sive, stimulant and opioid properties of M. speciosa (Horie et al.,
2005; Matsumoto et al., 2006, 2004, 2005a, 2005b; Takayama, 2004;
Takayama et al., 2002, 2006; Watanabe et al., 1997; Yamamoto
et al., 1999). Such pharmacological activities were often attributed to
the alkaloid contents of the leaf and were obtained through conven-
tional solvent extraction using dichloromethane or methanol.
With the increased concern for the environmental or health hazard
through the use of organic solvents for natural product extraction,
supercritical fluid extraction is gaining more interest in recent years.
Supercritical fluid extraction (SFE) using carbon dioxide (CO2) in its
supercritical state, i.e. pressure >1070.1 psi (73.8 bar) and temperature
>31.06 C, permits the process of extraction to be performed at a rel-
atively low pressure and at temperatures close to room temperature.
CO2 is an inert, non-toxic and environmentally friendly solvent. In
combination with the fact that CO2 immediately evaporates when
brought to atmospheric conditions, the extracts obtained are free from
chemically and thermally degraded compounds. The technique also
produces extracts of better quality than those extracted with organicPlease cite this article in press as: Tohar, N. et al., Chemical constituents and nitric o
speciosa leaves. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arsolvents, as the extracts are free from the trace of solvent. Even though
present at minute amounts, those organic solvents tend to contaminate
the extracts. In supercritical condition, CO2 possesses unusual proper-
ties of high compressibility, liquid-like density, high diffusivity, low
viscosity and low surface tension. Therefore, supercritical fluid shows
a greater ability to diffuse into the ultrafine matrix compared to the
organic solvents, improving yield of extraction of the desired materials
from complex matrices.
Therefore, the aim of the present study was to determine the opti-
mize SFE condition of the leaves extract that possesses the most potent
anti-inflammatory property with further analysis of the constituents
present in this active crude. To the best of our knowledge, this is the
first report communicated on the anti-inflammatory effect of the
SFE extracts of M. speciosa and the chemical constituents of the
extract that exhibited the most potent anti-inflammatory activity.
Inflammation is a wellness buzzword these days as it is the culprit
behind all diseases. There has been a global trend of increasing inci-
dence of diseases caused by inflammation over time in many countries.
In the Arabian region, a significant increase in the trend is evident over
time when there has been growing initiative to conduct comprehensive
collaborative multicentre studies for diseases such as arthritis, asthma,
inflammatory bowel disease (Crohn’s disease, ulcerative colitis and
indeterminate colitis) and other inflammatory diseases (Al-Hussaini
et al., 2016; Almoallim and Alharbi, 2014; El Mouzan et al., 2012;
Saadah et al., 2016). The magnitude of the inflammatory arthritis
problem in the Arabian peninsula has been published for many coun-
tries in the region (Saudi Arabia, Oman, Iraq and Kuwait) and the
prevalence of rheumatoid arthritis in the Arabian region has been esti-
mated to be 1–2% of the population (Al-Jarallah et al., 2013). Mean-
while, the occurrence rate for Crohn’s disease was 0.27 per 100,000
individuals has been reported in children aged 0–14 years for the per-
iod between 2003 and 2012 (El Mouzan et al., 2014). A large number of
steroids and non-steroidal anti-inflammatory drugs (NSAIDS) are
available commercially to treat inflammatory diseases. However,
despite their great number, their therapeutic efficiency seems to be
hampered because they are often associated with severe adverse side
effects. This current study has been conducted in hope to search for
less toxic anti-inflammatory drug where folk medicinal plants have
been established to have advantage in toxicity, due to their time tested
safety and efficacy. Findings from this study may bridge up the gaps in
inflammation research and could be put into beneficial use for nation
worldwide.2. Materials and methods
2.1. Plant material
Fresh leaves of M. speciosa were collected from the forest of
Sungai Setong, Kelantan, Malaysia, in November 2006. The
plant materials were identified by the herbarium authority at
the Department of Chemistry, University of Malaya, where
the plant specimen was deposited for future reference (Voucher
specimen no. KL5321). The leaves were dried under the shade,
assisted by electric light bulbs as a heat source of 35–40 C for
a period of one week. The shed dried leaves were ground by an
electrical blender to produce coarse powder of approximately
5 mm size particle.
2.2. Reagents
Carbon dioxide (99.995% purity, SFE grade), contained in a
cylinder with an eductor tube, was purchased from MOX
(Selangor, Malaysia). Analytical grade solvents, chemical
reagents and 95% ethanol were purchased from Merck. Thexide inhibitory activity of supercritical carbon dioxide extracts from Mitragyna
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alkanes used in the gas chromatography analysis were
obtained from SIGMA Chemical Co., USA. Antibiotic
(5000 U/mL penicillin and 5000 lg/mL streptomycin) and
Dulbecco’s Modified Eagle’s Media (DMEM) were obtained
commercially from FlowlabTM, Australia; foetal bovine serum
(FBS) was obtained fromMycoplexTM (PAA Lab. GmbH, Aus-
tria); recombinant mouse interferon gamma (IFN-c) was
obtained from BD Pharming, USA; lipopolysaccharide
(LPS) was from Escherichia coli (strain 0111:B4), and sul-
phanilamide and naphtylethylenediamine were obtained from
SIGMA Chemical Co., USA. Dimethyl sulfoxide (DMSO)
was purchased from Fisher Scientific, USA, and 3-(4,5-dime
thylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MMT)
from Fluka Chemie GmbH, Switzerland.
2.3. Supercritical fluid extraction (SFE)
Approximately 25 g of the dried ground leaves was loaded into a
100 mL stainless steel extraction vessel of the analytical-scale
SFT 100 XW SFE system (illustrated in Fig. 1). An orthogonal
test design L9 (3)
3 was employed in order to determine a suitable
extraction condition in a wide range with aminimum number of
trials, whereby the temperature, pressure and the percentage of
modifier (ethanol) were considered to be three major factors for
effective extraction. The combinations of three different levels
of each factor are listed in Table 1. In each test, two-step extrac-
tions were performed. First, the plant material was pre-Figure 1 The flow sheet of the analytica
Please cite this article in press as: Tohar, N. et al., Chemical constituents and nitric o
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due was re-extracted with CO2 modified with aqueous ethanol
solution in Step 2 (S2) as depicted in Table 2. CO2 was delivered
at the rate of 24 mL/min by the SFT-10 Constant Pressure
pump. For those studies involving modifier, ethanol solution
was added directly to the plant material in the extraction vessel
using an additional High Performance Liquid Chromatography
(HPLC) pump (Series II Isocratic HPLC pump) prior to the
extraction by supercritical CO2.
In both steps, after 60 minutes of static extraction (no CO2
flow), the sample material was subjected to dynamic extraction
by flowing the CO2 liquid (depressurized). The extraction pro-
cess was terminated when it was visually observed that there
was no more analyte being trapped in the collection vial
(exhaustive extraction). The extracts obtained were evaporated
to dryness under reduced pressure at 40 C (yielding dark
green residue). Then their final mass was weighed (Table 2)
and later checked by thin layer chromatography (TLC) for
their individual profile.
TLC separations were performed using aluminium sheets
pre-coated with 0.20 mm thick Silica gel 60 F254
(20 cm  20 cm) and developed with a mobile phase dichloro-
methane:methanol (96:4 v/v). The extracts were dissolved in
dichloromethane and applied to silica gel plates. TLC plates
were then visualized under UV light (254 and 365 nm) and fur-
ther sprayed with Dragendorff’s reagent to detect the presence
of alkaloidal compounds, which was indicated, by the presence
of orange colour spots.l-scale of SFT 100 XW SFE system.
xide inhibitory activity of supercritical carbon dioxide extracts from Mitragyna
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Table 1 The L9 (3)
3 orthogonal test design.
Test no. M: Matrix Factors
A: Pressure(psi) B: Temperature (C) C: Modifier (ethanol, %)a
1 M1 A1 1300 B1 40 C1 20
2 M2 A1 1300 B2 60 C2 40
3 M3 A1 1300 B3 80 C3 60
4 M4 A2 3000 B1 40 C2 40
5 M5 A2 3000 B2 60 C3 60
6 M6 A2 3000 B3 80 C1 20
7 M7 A3 5000 B1 40 C3 60
8 M8 A3 5000 B2 60 C1 20
9 M9 A3 5000 B3 80 C2 40
a Modifier (ethanol, %) = volume of added ethanol (mL)/sample mass (g)  100.
Table 2 The yields of L9 (3)
3 Orthogonal test crudes in the two-step extraction.
M Factors Extraction yield (%)a
A B C S1: Step 1 (100% CO2) S2: Step 2 (CO2 + modifier) Total: S1 + S2
Crude Crude
M1 A1 B1 C1 M1S1 0.18 M1S2 0.10 0.28
M2 A1 B2 C2 M2S1 0.11 M2S2 0.12 0.23
M3 A1 B3 C3 M3S1 0.10 M3S2 0.01 0.11
M4 A2 B1 C2 M4S1 0.69 M4S2 0.27 0.96
M5 A2 B2 C3 M5S1 0.96 M5S2 0.12 1.08
M6 A2 B3 C1 M6S1 0.93 M6S2 0.06 0.99
M7 A3 B1 C3 M7S1 1.08 M7S2 0.48 1.56
M8 A3 B2 C1 M8S1 1.36 M8S2 0.14 1.50
M9 A3 B3 C2 M9S1 1.26 M9S2 0.19 1.45
a Extraction yield (%) = amount of extract/sample mass  100.
4 N. Tohar et al.2.4. Nitric oxide inhibitory activity
2.4.1. Cell cultures and treatment
The murine monocytic macrophages cell line (RAW 264.7
cells) was purchased from American Type Culture Collection
(ATCC) and cultured in DMEM supplemented with 10%
FBS and 1% penicillin/streptomycin under 5% CO2 at
37 C. Cells at confluence of 80–90% were scrapped out and
centrifuged at 110g/4 C for 10 min. The cell viability and con-
centration were determined simultaneously using trypan blue
dye exclusion and a hemacytometer. Then, the cells were
seeded into 96-well plate at 5  104 cells/50 lL per well and
incubated for 2 h at 37 C, 5% CO2 to allow cell attachment.
After 2 h, unattached cells were carefully discarded. Attached
cells were then induced with 100 U/mL of IFN-c and 5 lg/
mL of LPS in the presence or absence of plant sample tested
at a final concentration of 100 lg/mL. The final concentration
of the sample vehicle (DMSO) in the reaction mixture was
0.1%. Untreated and drug controls were stimulated with
IFN-c/LPS and also had the same amount of DMSO in cul-
ture media. Cells were then incubated at 37 C, 5% CO2 for
17–20 h. (Syahida et al., 2006).
2.4.2. Griess assay
The production of NO was determined in the supernatants of
spent cell culture media by measuring the nitrite ion (NO2
 -Please cite this article in press as: Tohar, N. et al., Chemical constituents and nitric o
speciosa leaves. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arstable metabolite of NO) formation (Dirsch et al., 1998).
Briefly, 50 lL of Griess reagent (1% sulphanilamide and
0.1% naphtylethylenediamine dihydrochloride in 2.5%
H3PO4) was added to 50 lL of cell culture supernatant and
after an incubation time of 10 min, the colour density was mea-
sured at 550 nm on a micro plate reader (SpectraMax, Plus
384, Molecular Devices, Inc., USA) at room temperature.
Fresh culture medium was used as the blank in all the experi-
ments. The amount of NO2
 in the samples was calculated from
a sodium nitrite standard curve (0–100 lM) freshly prepared in
deionized water. The percentage of inhibition was calculated
against negative control cells (cells that were not treated but
induced with IFN-c/LPS and contained 0.1% DMSO)
(Syahida et al., 2006).
NO inhibitory ð%Þ ¼
NO2
 
control
 NO2
 
sample
NO2
 
control
 100%2.5. MTT cell viability assay
After the removal of culture media, the wells in micro titre
plate were topped up with 100 lL of DMEM followed by
the addition of 20 lL of MTT (5 mg/mL). The cells were incu-
bated under 5% CO2 at 37 C for 4 h. The formed formazan
crystals were dissolved in DMSO and the absorbance was
recorded at 570 nm on a micro plate reader (SpectraMax, Plusxide inhibitory activity of supercritical carbon dioxide extracts from Mitragyna
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Chemical constituents and nitric oxide inhibitory activity 5384, Molecular Devices, Inc., USA). The optical density (OD)
of the samples was compared to that of negative control cells
(untreated stimulated cells and contained 0.1% DMSO) to
obtain the percentage viability using the formula stated below
(Syahida et al., 2006):
Cell viability ð%Þ ¼ ODsample
ODcontrol
 100%2.6. Gas chromatographic analyses
The analyses were performed on the SFE extract that possesses
the strongest anti-inflammatory activity with no toxicity
effect.
2.6.1. Gas chromatography (GC)
GC analysis was carried out using a Shimadzu GC-2010 unit
equipped with FID. HP-5 fused silica capillary column of
5% phenyl 95% dimethylpolysiloxane (30 m  0.32 mm i.d.,
0.25 lm film thickness) was used. The oven temperature was
kept at 60 C for 1 min and programmed to 150 C at a rate
of 4 C/min. Then it is increased to 280 C at 3.5 C/min and
finally followed by 20 min under isothermal condition. Detec-
tor and injector temperatures were 300 and 250 C, respec-
tively. The carrier gas was helium (99.999%), adjusted to a
linear velocity of 30 cm/s and column flow of 1.21 mL/min.
Two lL of the diluted M5S1 (4000 ppm) was injected in split
less mode.
2.6.2. Gas chromatography–mass spectrometry (GC–MS)
GC–MS analysis was performed using a Shimadzu GC-2010
system coupled to a quadrupole mass spectrometer, MS-
QP2010 Plus with capillary GC conditions consistent with
those described above. Mass spectra were taken at 70 eV of
ionization energy, 0.5 s of scan time, ion source temperature
of 200 C and a mass range of 40–800 amu.
2.6.3. Identification of constituents
The characterization of components was based on a compar-
ison of their mass spectra with those of NIST08s.LIB mass
spectral database. The identifications were further confirmed
through comparison of Kovats indices (KI) with those
reported in the literature (Adam, 2001; Norsita et al., 2006a,
2006b). The Kovats index was determined with a standard
mixture of n-alkanes under the same chromatographic condi-
tions used when analyzing M5S1. Relative amounts of individ-
ual components were calculated by the area normalization
method without response factor correction. Three replicates
of gas chromatography analyses of M5S1 (crude with the
strongest anti-inflammatory activity without toxicity effect)
were performed. The precision was expressed as the relative
standard deviation (RSD) of the peak areas.
2.7. Statistical analysis
Results for NO inhibition and cell viability are expressed as
mean ± standard deviation (SD). Data were statistically
assessed using Graph pad prism version 5.0 for one-way anal-
ysis of variance (ANOVA) with Dunnett’s test. Differences
were considered statistically significant at p< 0.05.Please cite this article in press as: Tohar, N. et al., Chemical constituents and nitric o
speciosa leaves. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.ara3. Results and discussion
3.1. Supercritical fluid extraction (SFE)
Optimization of the experimental conditions signifies a crucial
step in the development of an efficient SFE method through
the adjustment of certain parameters that potentially affect
the extraction process. Optimization of the method can be per-
formed step-by-step or by using an experimental design.
Table 2 exhibits the results of the SFE of M. speciosa carried
out under different conditions. Pressure and temperature of
the fluid and percentage of the modifier were the selected fac-
tors assessed using a three-level orthogonal array design with
L9 (3)
3 matrix. Consequently, a complete evaluation of the
three factors will require three level tests, i.e., 27 tests. In order
to reduce the number of tests, an L9 (3)
3 orthogonal design
graph was employed, which reduced the total number of tests
to 9 (Table 1). A two-step extraction process was designed for
this study that included pre-extraction with pure CO2, makes it
a total of 18 tests to be executed.
In general, results depicted in Table 2 indicate the percent-
age of total yield (S1 + S2) improved with the increment in
pressure. At the static pressure of 3000 psi, the yield raised
as the temperature was increased from 40 to 60 C but dropped
slightly when the temperature was further increased from 60 to
80 C. As at 1300 psi and 5000 psi, a rise in temperature
resulted in lower yield.
The yield of extraction by pure CO2 also trailed the same
trend of increased yield for an increase in the pressure. A rise
in the pressure can improve the density of the fluid and thereby
resulting in an increased solvating power-giving rise to more
yields. At static pressure of 1500 psi, the yield gradually
reduced as the temperature increased. Within the pressure
range of 3000–5000 psi, the yield increased between the tem-
peratures of 40–60 C and somehow decreased from 60 to
80 C. Supercritical CO2 has a low polarity, making the extrac-
tion of polar analytes difficult. This limitation can usually be
overcome by adding small amounts of polar entrainer, such
as ethanol, to the supercritical CO2 in order to raise its solubi-
lizing power and thus increase the extraction efficacy. In our
experiment, the second step of each test in which the entrainer
was added in succession was also meant to be the exhaustive
process for completing the recovery of the high-molecular
mass components. Anyhow, the results revealed that the addi-
tion of entrainer (as modifier) negligibly improved the yield
than that of pure CO2. The increments in the yield were only
by 0.01–0.27% except in M7S2, where it was 0.48%.
Basically, in Step-1 (extraction by pure CO2) and Step-2
(extraction by CO2 + modifier) process, when the pressure
factor was set to 1300 psi, the yields were low and the total
yields were not more than 0.3%. A raise in the pressure from
3000 psi to 5000 psi resulted in a satisfactory improvement in
the yield (>0.9%), except for M4S1 (0.69%) for Step-1 pro-
cess. Overall, the total yields at 3000 psi and 5000 psi, were sig-
nificant (>0.9%).
3.2. TLC profile of the extracts
Each crude was examined to point out possible interesting dif-
ferences in the chemical composition obtained by different
extraction conditions.xide inhibitory activity of supercritical carbon dioxide extracts from Mitragyna
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orange spots for all crudes extracted at 5000 psi but not for
those extracted at 1300 and 3000 psi. This indicated that alka-
loidal compounds can only be furnished at relatively high pres-
sure and the addition of a polar solvent as modifier did not
give any effect in this aspect as shown by crudes extracted at
1300 and 3000 psi. Nevertheless, the orange colour spots of
the alkaloid were more intense in M7S2, M8S2 and M9S2
compared to M7S1, M8S1 and M9S1 respectively, conse-
quently suggesting that the addition of modifier might enhance
the yield of the alkaloid components.
3.3. Nitric oxide inhibitory activity
A total of 15 plant extracts were screened for their inhibitory
effect of NO release in RAW 264.7 cells. The overall efficacy
of all plant extracts on NO2
 production in IFN-c/LPS-
activated macrophage and cell viability on RAW 264.7 cells
are presented in Table 3. The plant extracts were considered
as having a strong, moderate or weak activity, if the inhibitory
of NO was more than 90%, between 50% and 89%, or less
than 50%, respectively, as compared to the control. In addi-
tion, the viability of RAW 264.7 cells assessed by MTT
method must be above 85% to prove that the decrease in
NO production was not a result of cell death (Mosmann,
1983). The results revealed that the extracts obtained at 3000
and 5000 psi, using pure CO2 exhibited stronger NO inhibitory
activity (lower production of NO) than those extracted in the
presence of modifier (Table 3). Hence suggesting that extrac-
tion with 100% CO2 alone is sufficient enough to enrich
extract with compound/s of potent anti-inflammatory prop-
erty. The results showed that six of the plant extracts demon-
strated 51–64%, and nine exhibited 16–48% inhibitory activity
towards NO production when tested at a final concentration of
100 lg/mL. Meanwhile, NOS inhibitor, N-nitro-arginine
methyl ester (L-NAME), used as the positive control in thisTable 3 The effect of M. speciosa SFE extracts on percentage of N
tested at final concentration of 100 lg/mL.
Sample SFE condition
M1S1 1300 psi, 40 C, 100% CO2
M1S2 1300 psi, 40 C, 20% EtOH
M2S2 1300 psi, 60 C, 40% EtOH
M4S1 3000 psi, 40 C, 100% CO2
M4S2 3000 psi, 40 C, 40% EtOH
M5S1 3000 psi, 60 C, 100% CO2
M5S2 3000 psi, 60 C, 60% EtOH
M6S1 3000 psi, 80 C, 100% CO2
M6S2 3000 psi, 80 C, 20% EtOH
M7S1 5000 psi, 40 C, 100% CO2
M7S2 5000 psi, 40 C, 60% EtOH
M8S1 5000 psi, 60 C, 100% CO2
M8S2 5000 psi, 60 C, 20% EtOH
M9S1 5000 psi, 80 C, 100% CO2
M9S2 5000 psi, 80 C, 40% EtOH
L-NAMEa
Values are expressed as means ± SD of three independent experiments.
a Positive control used for Griess assay.
Please cite this article in press as: Tohar, N. et al., Chemical constituents and nitric o
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any cytotoxic effect at the concentration of 250 lM (0.674 lg/
mL). Among those samples that moderately reduced NO pro-
duction, M5S1 showed the highest NO inhibitory activity at
60.08 ± 10.02% without any cytotoxicity effect (cell viability,
91.98 ± 5.58%). Thus, the optimal conditions determined
from these tests to furnish an extract that possesses the stron-
gest anti-inflammatory activity with no cytotoxicity effect were
extraction conducted using pure CO2 at 3000 psi of pressure
and temperature at 60 C. The constituents of this extract
(M5S1), were identified via GC and GC–MS analyses.
3.4. GC and GC–MS analyses of M5S1
Fig. 2 depicts the GC–MS profile of the SFE extract that pos-
sesses the strongest NO inhibitory activity without showing
toxicity effect towards the test cells (M5S1). Table 4 lists the
compounds identified in M5S1, the relative GC peak areas
of these compounds and their experimental KI. RSD values
less than 10% were considered good precision for a method.
The gas chromatographic profile shows 15 identifiable compo-
nents that represented 93.53% of the total peak area. The
prominent constituents were fatty acids, accumulated to
39.01% of the total yield. The rest of the crude was made up
of four hydrocarbons (36.67%), three phytosterols (9.32%),
two esters (3.45%), two alcohols (2.30%) and last but not
least, a tocochromanol (2.78%). Palmitic acid, at 34.90%
was the most abundant constituent in the crude matrix fol-
lowed by heptacosane (18.56%) and nonacosane (11.00%).
Fatty acids have been identified to involve in the formation
of healthy cell membranes, proper development and function-
ing of the brain and nervous system, regulating blood pressure
and viscosity as well as immune and inflammatory responses
(Eastwood, 1997; Sa´nchez-Vicente et al., 2009). This may
explain the NO inhibition exhibited by M5S1, as it is rich in
palmitic acid that has been communicated for its anti-O inhibition and cell viability of RAW 264.7 macrophage cells
Result
NO inhibition (%) Cell viability (%)
21.13 ± 4.10 65.41 ± 16.06
56.86 ± 8.83 68.51 ± 15.55
63.83 ± 4.94 69.40 ± 16.58
54.37 ± 7.19 79.39 ± 6.26
42.22 ± 4.54 88.46 ± 9.47
60.08 ± 10.02 91.98 ± 5.58
24.56 ± 9.78 88.10 ± 15.22
44.79 ± 1.62 94.45 ± 11.35
40.35 ± 11.57 75.61 ± 6.38
51.44 ± 15.02 95.28 ± 8.66
19.88 ± 6.02 92.92 ± 14.08
48.24 ± 0.88 88.33 ± 13.65
46.65 ± 2.31 93.95 ± 14.70
54.91 ± 2.84 91.32 ± 11.00
16.68 ± 1.28 72.24 ± 6.32
86.65 ± 6.12 95.52 ± 3.50
NT; not tested.
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Figure 2 The GCMS total ion chromatogram ofM. speciosa extract obtained by SFE that possesses the strongest nitric oxide inhibitory
activity without cytotoxicity effect, M5S1.
Table 4 Constituents identified in the leaves ofM. speciosa extract obtained by SFE that possesses the strongest nitric oxide inhibitory
activity without cytotoxicity effect, M5S1.
No. Identified compounds KI Relative content (%)a RSD (%) ID
1 a-Bisabolol 1687 1.15 9.1 RI
2 Z-Nuciferol acetate 1832 2.35 2.3 RI
3 9 (11),15-diene-Isopimara 1907 3.54 7.5 RI
4 Palmitic acid 1984 34.90 1.5 RI, MS, CO
5 2,3-Dimethoxypropyl tetradecanoate 2073 1.10 1.3 RI
6 Methyl ester oleic acid 2090 2.20 5.7 RI, MS
7 Nezukol 2132 1.15 9.5 RI
8 Stearic acid 2166 1.91 9.0 RI, MS,
9 2,10-Dimethyloctacosane 2649 3.57 2.3 RI, MS
10 Heptacosane 2702 18.56 5.7 RI, MS
11 Campesterol 2723 1.66 3.7 RI, MS
12 b-/c-Stigmasterol* 2731 0.99 6.0 RI, MS
13 b-/c-Sitosterol* 2739 6.67 3.5 RI, MS
14 Nonacosane 2904 11.00 2.5 RI, MS
15 b-/c-Tocopherol* 3036 2.78 9.5 RI, MS
KI; Kovats indices calculated on HP-5 column, RSD; relative standard deviation, ID; means of identification, RI; comparison of Kovats indices
with literature values, MS; mass spectral data, CO; co-injection with standard.
a Percentage of total FID peak area obtained on HP-5 column.
* Correct isomer not identified.
Chemical constituents and nitric oxide inhibitory activity 7inflammatory activity. Ester bond hydrolysis of membrane
phospholipids by phospholipase A2 and consequent release
of fatty acids are the initiating steps of inflammation. There-
fore, phospholipase A2 inhibitory is one of the ways to control
inflammation. The structural and kinetics studies have
revealed that palmitic acid is an inhibitor of phospholipase
A2, and hence, is an anti-inflammatory compound (Aparna
et al., 2012).
Furthermore, the appearance of phytosterols may also
enhance the NO inhibition activity exhibited by M5S1 as theyPlease cite this article in press as: Tohar, N. et al., Chemical constituents and nitric o
speciosa leaves. Arabian Journal of Chemistry (2016), http://dx.doi.org/10.1016/j.arahave been reported to possess anti-inflammatory (Park et al.,
2001), antioxidant (Yoshida and Niki, 2003) and angiogenic
(Choi et al., 2002) activities. b-Sitosterol, stigmasterol and
campesterol were detected at an appreciable amount, i.e.,
6.67%, 0.99% and 1.66%, respectively. Along with these phy-
tosterols, the presence of tocopherol that constituted 2.78% of
M5S1, although present at a low concentration, might con-
tribute towards the observed NO inhibition activity through
its antioxidant properties, especially against lipid peroxidation
in biological membranes (Gast et al., 2005).xide inhibitory activity of supercritical carbon dioxide extracts from Mitragyna
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8 N. Tohar et al.Interest has long been focused on the organic solvent
extracts of M. speciosa obtained through cool percolation or
hot extraction (Avula et al., 2015; Beckett et al., 1965;
Kitajima et al., 2006; Seaton et al., 1960; Shellard et al.,
1978). Almost all of the previous biological studies have been
conducted on the alkaloidal fractions and its major alkaloid
constituents (Idayu et al., 2011; Kong et al., 2011;
Parthasarathy et al., 2009; Sabetghadam et al., 2013; Shaik
Mossadeq et al., 2009; Utar et al., 2011). There is lack of stud-
ies on the non-alkaloidal crude. In this current investigation,
studies have been done on the non-organic solvent crudes that
consist of not only the alkaloids but also the non-alkaloidal
fractions. It highlighted the advantage of the SFE technique
in affording the non-alkaloid anti-inflammatory compounds
such as campesterol, stigmasterol, sitosterol and palmitic acid.
This is the first report revealing non-alkaloidal extract of M.
speciosa exhibited NO inhibition activity, which may be of
important potential in anti-inflammatory treatment.4. Conclusion
In conclusion, this study has identified the nitric oxide inhibitory activ-
ity of 15 selected SFE extracts of M. speciosa and M5S1 possessed the
strongest activity without cytotoxic effect (NO inhibitory activity at
60.08 ± 10.02% and cell viability, 91.98 ± 5.58%). It is noteworthy
that M5S1 was constituted largely by fatty acid, in particular palmitic
acid (34.90%), which has been claimed as an anti-inflammatory com-
pound. Parameters for the extraction of M5S1 are determined as the
optimal SFE condition (extraction under pure CO2, pressure:
3000 psi, temperature: 60 C) to furnish extract that possesses the high-
est anti-inflammatory activity without any toxicity. The inference from
the observed nitric oxide inhibitory activity supports the traditional
use of M. speciosa in the treatment of muscle pain and fever.
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